Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluating the Safety and Immunogenicity of MTBVAC

The purpose of this study is to evaluate the safety and immunogenicity of MTBVAC in adolescents and adults living with and without HIV in South Africa

Participants needed: 276
Trial details
Phase: Phase 2Age: 12-55Biological sex: AllType: InterventionalSponsor: HIV Vaccine Trials NetworkUpdated: Mar 12, 2026Locations: 16
Eligibility criteria

Age of 12 through 55 years, on the day of enrollment. [+19]

Weight less than 40 kg [+35]

Status: Not yet recruiting

Safety & Immunogenicity of 426c.Mod.Core-C4b Vaccine With 3M-052-AF+Alum in Infants Perinatally Exposed to HIV But Uninfected

The purpose of this study is to evaluate the safety and immunogenicity of 426c.Mod.Core-C4b vaccine adjuvanted with 3M-052-AF + Alum in infants with perinatal HIV exposure who are without HIV at birth

Participants needed: 22
Trial details
Phase: Phase 1Age: Up to 7Biological sex: AllType: InterventionalSponsor: HIV Vaccine Trials NetworkUpdated: Dec 9, 2025Locations: 1
Eligibility criteria

Mother's age is at least 18 years and is willing and able to provide written inf... [+11]

Any World Health Organization (WHO) grade IV illness within 1 year prior to stud... [+22]